Loading...

Inventiva S.A.

IVEVFPNK
Healthcare
Biotechnology
$5.33
$0.00(0.00%)
U.S. Market opens in 0h 53m

Inventiva S.A. Fundamental Analysis

Inventiva S.A. (IVEVF) shows moderate financial fundamentals with a PE ratio of -8.21, profit margin of -62.79%, and ROE of 18.92%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.72
Current Ratio3.16

Areas of Concern

Operating Margin-25.23%
We analyze IVEVF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5799.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5799.5/100

We analyze IVEVF's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVEVF struggles to generate sufficient returns from assets.

ROA > 10%
-1.42%

Valuation Score

Excellent

IVEVF trades at attractive valuation levels.

PE < 25
-8.21
PEG Ratio < 2
-0.72

Growth Score

Weak

IVEVF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IVEVF maintains a strong and stable balance sheet.

Debt/Equity < 1
-2.10
Current Ratio > 1
3.16

Profitability Score

Weak

IVEVF struggles to sustain strong margins.

ROE > 15%
18.92%
Net Margin ≥ 15%
-62.79%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVEVF Expensive or Cheap?

P/E Ratio

IVEVF trades at -8.21 times earnings. This suggests potential undervaluation.

-8.21

PEG Ratio

When adjusting for growth, IVEVF's PEG of -0.72 indicates potential undervaluation.

-0.72

Price to Book

The market values Inventiva S.A. at -101.90 times its book value. This may indicate undervaluation.

-101.90

EV/EBITDA

Enterprise value stands at -5.11 times EBITDA. This is generally considered low.

-5.11

How Well Does IVEVF Make Money?

Net Profit Margin

For every $100 in sales, Inventiva S.A. keeps $-62.79 as profit after all expenses.

-62.79%

Operating Margin

Core operations generate -25.23 in profit for every $100 in revenue, before interest and taxes.

-25.23%

ROE

Management delivers $18.92 in profit for every $100 of shareholder equity.

18.92%

ROA

Inventiva S.A. generates $-1.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.42%

Following the Money - Real Cash Generation

Operating Cash Flow

Inventiva S.A. generates limited operating cash flow of $-22.91M, signaling weaker underlying cash strength.

$-22.91M

Free Cash Flow

Inventiva S.A. generates weak or negative free cash flow of $-22.96M, restricting financial flexibility.

$-22.96M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

IVEVF converts -16.57% of its market value into free cash.

-16.57%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.21

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.72

vs 25 benchmark

P/B Ratio

Price to book value ratio

-101.90

vs 25 benchmark

P/S Ratio

Price to sales ratio

112.50

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.16

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

18.92

vs 25 benchmark

ROA

Return on assets percentage

-1.42

vs 25 benchmark

ROCE

Return on capital employed

-0.83

vs 25 benchmark

How IVEVF Stacks Against Its Sector Peers

MetricIVEVF ValueSector AveragePerformance
P/E Ratio-8.2129.06 Better (Cheaper)
ROE1891.91%646.00% Excellent
Net Margin-6278.99%-44088.00% (disorted) Weak
Debt/Equity-2.100.33 Strong (Low Leverage)
Current Ratio3.164.49 Strong Liquidity
ROA-141.91%-15444.00% (disorted) Weak

IVEVF outperforms its industry in 4 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inventiva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ